Fill out the form to download your copy and see the results.

Use of Digital Biomarkers in a Parkinson's Disease Open-label Extension Study for Frequent and Objective Assessment of Treatment Response

 

In this poster you will learn:

  • Given the natural fluctuating course of Parkinson’s Disease (PD) and the lack of scalability in traditional clinical measures of PD, measuring treatment response in PD can be challenging. 
  • Objective, frequent, and remote measurement of core PD symptomatology using novel technology can facilitate the evaluation of benefits from new therapeutic interventions. 
  • Here, we describe a study design that utilizes smartphones to calculate visual and auditory biomarkers of PD symptomatology and determine symptom severity in response to treatment.